Serum 25-hydroxyvitamin D level, smoking and lung function in adults: the HUNT Study Source: Eur Respir J 2015; 46: 355-363 Year: 2015
Serum 25-hydroxyvitamin D levels and lung function in adults with asthma: the HUNT Study Source: Eur Respir J 2015; 45: 1019-1026 Year: 2015
A nested case-control study of serum 25-hydroxyvitamin D levels and risk of adult-onset asthma – The HUNT study Source: Annual Congress 2011 - New insights in the incidence, variation and risk factors of asthma Year: 2011
Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study Source: Eur Respir J 2012; 39: 1443-1448 Year: 2012
C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008
Plasma adiponectin and risk of asthma: observational and Mendelian randomization studies in up to 557,801 individuals Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Age at menopause and lung function: a Mendelian randomisation study Source: Eur Respir J, 54 (4) 1802421; 10.1183/13993003.02421-2018 Year: 2019
Clinical significance of serum osteopontin levels in lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017
The study on the association of serum C-reactive protein level with the risk of lung cancer Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Age at menopause and lung function: A Mendelian randomization study Source: International Congress 2018 – Role of omics in population studies Year: 2018
C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002
Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology Source: Eur Respir J 2013; 41: 410-416 Year: 2013
Association of serum ROM levels with different histopathological types of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 325s Year: 2005
Passive smoking in relation to lung cancer incidence and histologic types in Norwegian adults: the HUNT study Source: Eur Respir J, 50 (4) 1700824; 10.1183/13993003.00824-2017 Year: 2017
Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
Alpha1-antitrypsin blood levels and lung function in the population-based SAPALDIA cohort Source: Eur Respir J 2005; 26: Suppl. 49, 219s Year: 2005
Clinical significance of serum adipokines levels in lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
ABO phenotypes and inflammation-related predictors of lung cancer mortality: the Copenhagen Male Study - a 16-year follow-up Source: Eur Respir J 2007; 30: 13-20 Year: 2007